Lumiera Health Inc.
NHPH.V
TSX
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -36.76% | -48.96% | -55.48% | -4.47% | 11.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.76% | -48.96% | -55.48% | -4.47% | 11.07% |
| Cost of Revenue | -25.38% | -40.38% | -85.58% | 169.63% | 17.87% |
| Gross Profit | -54.52% | -60.74% | -27.66% | -150.87% | 1.90% |
| SG&A Expenses | -77.31% | -81.25% | -85.95% | -32.66% | -42.12% |
| Depreciation & Amortization | -83.54% | -83.73% | -83.73% | -21.78% | 3.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -67.43% | -73.10% | -85.80% | -2.40% | -33.87% |
| Operating Income | 82.06% | 86.04% | 98.02% | 1.42% | 44.58% |
| Income Before Tax | 70.37% | 68.71% | 85.03% | -245.49% | 8.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 70.37% | 68.71% | 85.03% | -245.49% | 8.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.37% | 68.71% | 85.03% | -245.49% | 8.82% |
| EBIT | 82.06% | 86.04% | 98.02% | 1.42% | 44.58% |
| EBITDA | 81.93% | 86.21% | 98.91% | 0.00% | 46.79% |
| EPS Basic | 71.43% | 70.00% | 83.33% | 31.40% | 19.23% |
| Normalized Basic EPS | 69.23% | 66.67% | 89.47% | 91.18% | 18.75% |
| EPS Diluted | 71.43% | 70.00% | 83.33% | 31.40% | 19.23% |
| Normalized Diluted EPS | 69.23% | 66.67% | 89.47% | 91.18% | 18.75% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 403.27% | 12.09% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 403.27% | 12.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
